BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30060952)

  • 21. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.
    Jiang G; Fang H; Shang X; Chen X; Cao F
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-induced cell division is controlled by the adaptor Grb14 in a Chfr-dependent manner.
    Perdereau D; Cailliau K; Browaeys-Poly E; Lescuyer A; Carré N; Benhamed F; Goenaga D; Burnol AF
    Cell Signal; 2015 Apr; 27(4):798-806. PubMed ID: 25578860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.
    Johnson DP; Spitz GS; Tharkar S; Quayle SN; Shearstone JR; Jones S; McDowell ME; Wellman H; Tyler JK; Cairns BR; Chandrasekharan MB; Bhaskara S
    Oncotarget; 2015 Mar; 6(7):4863-87. PubMed ID: 25605023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59.
    Son SW; Cho E; Cho H; Woo SR; Lee HJ; Oh SJ; Kim S; Kim JH; Chung EJ; Chung JY; Kim MG; Song KH; Kim TW
    Sci Rep; 2022 May; 12(1):8652. PubMed ID: 35606403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.
    Brodie SA; Li G; Harvey D; Khuri FR; Vertino PM; Brandes JC
    Oncotarget; 2015 Oct; 6(31):30773-86. PubMed ID: 26356822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.
    Shtivelman E
    Mol Cancer Res; 2003 Nov; 1(13):959-69. PubMed ID: 14638868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.
    Privette LM; González ME; Ding L; Kleer CG; Petty EM
    Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells.
    Cal R; García-Arguinzonis M; Revuelta-López E; Castellano J; Padró T; Badimon L; Llorente-Cortés V
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):369-77. PubMed ID: 23241409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction between Chfr and Kif22 controls genomic stability.
    Maddika S; Sy SM; Chen J
    J Biol Chem; 2009 May; 284(19):12998-3003. PubMed ID: 19321445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHFR suppression by hypermethylation sensitizes endometrial cancer cells to paclitaxel.
    Wang X; Yang Y; Xu C; Xiao L; Shen H; Zhang X; Li T; Li X
    Int J Gynecol Cancer; 2011 Aug; 21(6):996-1003. PubMed ID: 21792009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNP rs4971059 predisposes to breast carcinogenesis and chemoresistance via TRIM46-mediated HDAC1 degradation.
    Zhang Z; Liu X; Li L; Yang Y; Yang J; Wang Y; Wu J; Wu X; Shan L; Pei F; Liu J; Wang S; Li W; Sun L; Liang J; Shang Y
    EMBO J; 2021 Oct; 40(19):e107974. PubMed ID: 34459501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRG1 Governs Nanog Transcription in Early Mouse Embryos and Embryonic Stem Cells via Antagonism of Histone H3 Lysine 9/14 Acetylation.
    Carey TS; Cao Z; Choi I; Ganguly A; Wilson CA; Paul S; Knott JG
    Mol Cell Biol; 2015 Dec; 35(24):4158-69. PubMed ID: 26416882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?
    Keller JA; Erson-Bensan AE; Petty EM
    Cancer Biol Ther; 2010 Nov; 10(9):942-4. PubMed ID: 21057211
    [No Abstract]   [Full Text] [Related]  

  • 34. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity.
    Oh YM; Yoo SJ; Seol JH
    Biochem Biophys Res Commun; 2007 Jun; 357(3):615-9. PubMed ID: 17442268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification.
    Kwon DH; Eom GH; Ko JH; Shin S; Joung H; Choe N; Nam YS; Min HK; Kook T; Yoon S; Kang W; Kim YS; Kim HS; Choi H; Koh JT; Kim N; Ahn Y; Cho HJ; Lee IK; Park DH; Suk K; Seo SB; Wissing ER; Mendrysa SM; Nam KI; Kook H
    Nat Commun; 2016 Feb; 7():10492. PubMed ID: 26832969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway.
    Srinual S; Chanvorachote P; Pongrakhananon V
    Int J Oncol; 2017 Apr; 50(4):1341-1351. PubMed ID: 28259926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Abl induces stabilization of histone deacetylase 1 (HDAC1) in a kinase activity-dependent manner.
    Aoyama K; Yamaguchi N; Yuki R; Morii M; Kubota S; Hirata K; Abe K; Honda T; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    Cell Biol Int; 2015 Apr; 39(4):446-56. PubMed ID: 25561363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
    Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
    Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHFR functions as a ubiquitin ligase for HLTF to regulate its stability and functions.
    Kim JM; Cho EN; Kwon YE; Bae SJ; Kim M; Seol JH
    Biochem Biophys Res Commun; 2010 May; 395(4):515-20. PubMed ID: 20388495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Stil protein regulates centrosome integrity and mitosis through suppression of Chfr.
    Castiel A; Danieli MM; David A; Moshkovitz S; Aplan PD; Kirsch IR; Brandeis M; Krämer A; Izraeli S
    J Cell Sci; 2011 Feb; 124(Pt 4):532-9. PubMed ID: 21245198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.